Literature DB >> 22737506

Epidemiology of HTLV-1 in Neyshabour, Northeast of Iran.

M R Hedayati-Moghaddam1, F Fathimoghadam, I Eftekharzadeh Mashhadi, L Soghandi, H R Bidkhori.   

Abstract

BACKGROUND: HTLV-1 infection is endemic in Mashhad, Northeast of Iran. This study was designed to assess the epidemiology of HTLV-1 and potential risk factors in Neyshabour, Northeastern Iran.
METHODS: All those who referred to Iranian Academic Center for Education, Culture and Research (ACECR)- Mashhad Laboratory in Neyshabour for evaluation of HTLV-I by ELISA, were tested using WB if the ELISA result was positive. A questionnaire about risk factors of infection was completed for all cases.
RESULTS: HTLV-1 infection was positive in 7.2% (35/483) of the participants according to the results of enzymelinked immunosorbent assay (ELISA) and western blot (WB) tests. Infection was significantly associated with age, family size, income and blood transfusion. However, gender, education, birthplace, race, marital status, and history of surgery, dentistry, traditional cupping, and hospitalization showed no significant relation.
CONCLUSION: It seems that HTLV-I infection is highly endemic in Neyshabour and it is seems that more effective treatment strategies are needed.

Entities:  

Keywords:  Epidemiology; HTLV-1 infection; Iran

Year:  2011        PMID: 22737506      PMCID: PMC3371930     

Source DB:  PubMed          Journal:  Iran Red Crescent Med J        ISSN: 2074-1804            Impact factor:   0.611


Introduction

Human T Lymphotrophic Virus type I (HTLV-I), a Deltavirus member of Retroviridae family has a cosmopolitan distribution and currently more than 20 million people in the world are infected with this virus. [1] Prevalence rate of more than 1% in the general population, Caribbean Basin, Central Africa, and South Japan are assumed as an endemic area for HTLV-I.[2] Northeast of Iran, Mashhad, the capital of Razavi Khorasan Province, is endemic for HTLV with a prevalence of 3% among general population.[3] In 2002, screening by enzyme-linked immunosorbent assay (ELISA) test for evaluation of HTLV infection revealed a prevalence of 3.4% in general population of Neyshabour, as the third largest city of the province.[4] However, confirming of the results by western blot (WB) was not performed in that study, and the precise prevalence of HTLV infection in this city is not determined yet. This study aims to evaluate the prevalence of HTLV infection and the sociodemographic and other potential risk factors among those who referred to Iranian Academic Center for Education, Culture and Research (ACECR)-Mashhad Clinical Laboratory in the city of Neyshabour, Northeastern Iran for the evaluation of HTLV-I.

Materials and Methods

From February to August 2009 in a non-random sampling and a cross-sectional descriptive-analytic study, all those who referred to ACECR-Mashhad Clinical Lab in Neyshabour, Northeastern Iran for the evaluation of HTLV-1 infection (n=511) were enrolled. After a thorough explanation of the research project and invitation to participate in the study, a questionnaire on demographic features and potential risk factors of the infection such as a history of blood transfusion, surgery, dentistry procedures, being hospitalized, traditional cupping, and tattooing was completed for each case. Also an informed consent was obtained from each participant. After testing the blood samples by ELISA (ELISA-4; Dia. Pro diagnostic Bioprobes, Italy), which was ordered by physicians of the city, WB analysis (HTLV blot 2.4 kit, MP diagnostic Ltd., Germany) was used for the confirmation of positive ELISA results. Criteria for HTLV-I sero-positivity in WB test was reactivity to GAG (p19 with or without p24) and two ENV (GD21 and rgp 46-I) proteins. Data were analyzed using SPSS software (Version 13.0, Chicago, IL, USA) by Chi-Square and t tests. P values <0.05 were considered statistically significant.

Results

The mean age of participants was 37.4±15.4 years (Range: 5-84 years). Four hundred and four cases (79.1%) were female, 94.9% were at least once married, 86.7% were born in Razavi Khorasan Province and 96.6% had Fars ethnicity. 27.6% lived in a small family size (≤2) and 27.2% in a large family size (>5). Also 14.9% were illiterate, 36.4% had 1-8 years of education, 30.8% had 9-12 years of education, and 17.9% had an academic educational level. Among the participants, 12.9% were governmental employee, 17.6% non-governmental, 5.0% student, and 64.5% were unemployed. 60.6% had less than 300 US$ monthly income, 33.2%, 300-500 US$, and 6.3% more than 500 US$. Pregnancy was the main reason (28.4%, 145/511) for which the participants were referred to the lab for evaluation of HTLV-1 infection. Other reasons were the patient’s request (21.7%, 111/511), being candidate for an operation (9%, 46/511), presence of indicative symptoms in patients (7.4%, 38/511), a positive history of the infection in at least one of the family members (2.2%, 11/511), and other reasons (4.1%, 21/511). The reason for patient’s referral was not determined in 139 cases (27.2%). History of blood transfusion was noticed in 4.6%, surgery in 39.4%, traditional cupping in 8.0%, dentistry procedures in 18.9%, hospitalization in 31.5%, tattooing in 1.2%, and imprisonment in 0.6% of the participants. ELISA was positive in 62 (12.1%) and 3 patients (0.6%) had borderline results. Among these two groups, WB analysis was performed for 37 cases (28 did not agree to perform WB). The WB result was positive in 94.6% (35/37); however the result was indeterminate in one case. Overall prevalence of HTLV infection was 7.2% (35/483) based on ELISA and WB results. Infection was significantly correlated with age (p<0.001), family size (p=0.004), income (p<0.001) and history of blood transfusion (p=0.024) (Table 1 and Table 2). Age was the most important factor which had the highest impact on the infection (OR= 8.05).
Table 1

Comparison of demographic features of HTLV positive and negative cases

No.Positive cases (%)Odd Ratio95% CIP value
Age<301973 (1.5)8.052.43-26.73<0.001
≥3028031 (11.1)
SexMale9710 (10.3)0.600.28-1.310.196
Female38525 (6.5)
Birth placeKhorasan Razavi42232 (7.6)0.610.08-4.690.631
Other provinces211 (4.8)
RaceFars40729 (7.1)0.930.12-7.330.946
Others151 (6.7)
Marital statusMarried41826 (6.2)2.600.93-7.270.060
Non-married345 (14.7)
Family size≤21142 (1.8)6.421.51-27.370.004
>228229 (10.3)
Education0-8 years22321 (9.4)0.500.24-1.070.070
≥9 years22111 (5.0)
JobEmployed/Retired12612 (9.5)0.710.34-1.510.337
Non-employed28620 (7.0)
Income (Monthly)<300 US $2247 (3.1)5.222.15-12.60<0.001
≥300 US $14621 (14.4)
Table 2

Comparison of risk factors of HTLV positive and negative cases

No.Positive cases (%)Odd Ratio95% CIP value
Reasons of referring to LabScreening a1892 (1.1)15.063.50-64.75<0.001
Non-screening17324 (13.9)
History of blood transfusionPositive314 (12.9)3.501.11-11.080.024
Negative44318 (4.1)
History of SurgeryPositive18716 (8.6)0.550.26-1.160.110
Negative28614 (4.9)
History of DentistryPositive939 (9.7)0.570.26-1.290.174
Negative38022 (5.8)
History of traditional cuppingPositive381 (2.6)2.640.35-19.960.328
Negative43529 (6.7)
History of HospitalizationPositive14910 (6.7)0.910.42-2.010.823
Negative32420 (6.2)

a Screening included pregnancy and being candidate from operation.

a Screening included pregnancy and being candidate from operation.

Discussion

Areas with sero-prevalence of more than 2% are categorized as high endemic regions.[5] The current study showed a high prevalence of HTLV-I infection in a non-random sample of Neyshabour population. The high seroprevalence of HTLV infection by ELISA test had been previously shown in some studies. In 2002, Farid et al. revealed that the HTLV prevalence was 3.4% in the general population of Neyshabour.[4] HTLV infection is mainly localized in northeast of Iran including Mashhad and neighbor cities, and studies in several other areas, which are predominantly carried on blood donors demonstrated a lower prevalence from 0.01% to 0.62%.[6][7][8] On the other hand, many studies have shown that HTLV infection in high risk groups such as multitransfused patients throughout the country is more prevalent (1%-6.8%).[6][8][9][10][11][12] High prevalence of HTLV-1 infection found in this study might be due to a possible higher risk of infection in this sample, because our cases were referred for evaluation of HTLV by physicians of the city. There was a correlation between referral reasons and HTLV-1 seropositivity. Pregnancy was the main reason for referral (28.4%). The prevalence of the infection among pregnant women in our study was 1.39% which was a little higher than the same prevalence among pregnant women in Mashhad (0.9%).[13] Nevertheless, screening of HTLV infection by ELISA is not included in the national program of pre-natal care, but physicians refer pregnant women for HTLV serology test. However, HTLV screening is performed regularly in the blood donors of Khorasan provinces (North, South and Razavi) according to the guidelines of “Iranian Blood Ttransfusion Organization”. [14] In our study, 9% of the participants were referred by a surgeon for the evaluation of HTLV infection prior to the surgical operations which seems to become, a common reason for referral. The results of our study showed that the prevalence of the infection in patients who had been referred by a physician for screening (surgery/pregnancy) is relatively low, so it would be more efficient to only refer high risk or suspected cases for the screening. In this study, the correlation between some of the demographic features including age, family size, and income and HTLV infection was significant. However, birthplace, race, marital status, job, and literacy level did not have a significant impact on the infection. Several other studies represented age to have correlation with the infection.[15],[16] In evaluation of risk factors for HTLV sero-positivity, Murphy et al. showed no association between HTLV-I seropositivity and educational attainment, income or occupation. [17] However, education and ethnic affiliations were shown to have a relation with the infection.[15][18][19] On the other hand, there are some studies, presenting exactly the opposite results. A study in Panama demonstrated that race and socioeconomic factors were not associated with infection.[20] Thus, it seems that several other factors such as cultural and other demographic differences probably affect these associations. None of the potential non-sociodemographic risk factors of the infection including history of surgery, dentistry procedures, traditional cupping and hospitalization was found to be associated with the infection. However, our study is in consistent with several investigations and showed that blood transfusion had a correlation with HTLV infection.[15][21][22] As a conclusion, high prevalence of HTLV-1 infection, which was clearly shown in the current study,not only approves the previous findings, but also necessitates more attention and planning for the control of the infection in the Northeast of Iran.
  12 in total

1.  Prevalence of HTLV type I infection in Iran: a serological and genetic study.

Authors:  B Safai; J L Huang; E Boeri; R Farid; J Raafat; P Schutzer; R Ahkami; G Franchini
Journal:  AIDS Res Hum Retroviruses       Date:  1996-08-10       Impact factor: 2.205

2.  HTLV-1 and HTLV-2 infections in HIV-infected individuals from Santos, Brazil: seroprevalence and risk factors.

Authors:  A Etzel; G Y Shibata; M Rozman; M L Jorge; C D Damas; A A Segurado
Journal:  J Acquir Immune Defic Syndr       Date:  2001-02-01       Impact factor: 3.731

3.  A case-control study of risk factors for seropositivity to human T-lymphotropic virus type I (HTLV-I) in Jamaica.

Authors:  E L Murphy; R Wilks; B Hanchard; B Cranston; J P Figueroa; W N Gibbs; J Murphy; W A Blattner
Journal:  Int J Epidemiol       Date:  1996-10       Impact factor: 7.196

4.  HTLV-1 infection in a population-based cohort of older persons in Guinea-Bissau, West Africa: risk factors and impact on survival.

Authors:  M Melbye; A G Poulsen; D Gallo; J B Pedersen; R J Biggar; O Larsen; F Dias; P Aaby
Journal:  Int J Cancer       Date:  1998-05-04       Impact factor: 7.396

5.  Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors.

Authors:  H H Lee; P Swanson; J D Rosenblatt; I S Chen; W C Sherwood; D E Smith; G E Tegtmeier; L P Fernando; C T Fang; M Osame
Journal:  Lancet       Date:  1991-06-15       Impact factor: 79.321

6.  A study of HTLV-I and its associated risk factors in Trinidad and Tobago.

Authors:  W A Blattner; C Saxinger; D Riedel; B Hull; G Taylor; F Cleghorn; R Gallo; B Blumberg; C Bartholomew
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

7.  HTLV-I/II prevalence in different geographic locations.

Authors:  Hans Vrielink; Henk W Reesink
Journal:  Transfus Med Rev       Date:  2004-01

8.  Seroprevalence and risk factors for human T-cell lymphotropic virus (HTLV-I) infection among ethnically and geographically diverse Peruvian women.

Authors:  C Sanchez-Palacios; E Gotuzzo; A-M Vandamme; Y Maldonado
Journal:  Int J Infect Dis       Date:  2003-06       Impact factor: 3.623

9.  Human T-cell lymphotropic virus type I (HTLV-I) seroepidemiology and risk factors in metropolitan Panamá.

Authors:  W C Reeves; C Saxinger; M M Brenes; E Quiroz; J W Clark; M W Hoh; W A Blattner
Journal:  Am J Epidemiol       Date:  1988-03       Impact factor: 4.897

10.  Survey of the seroprovalence of HTLV I/II in hemodialysis patients and blood donors in Urmia.

Authors:  Zakieh Rostamzadeh Khameneh; Mohammad Baradaran; Nariman Sepehrvand
Journal:  Saudi J Kidney Dis Transpl       Date:  2008-09
View more
  20 in total

1.  Assessment of HTLV-1 proviral load, LAT, BIM, c-FOS and RAD51 gene expression in adult T cell leukemia/lymphoma.

Authors:  Samaneh Ramezani; Abbas Shirdel; Houshang Rafatpanah; Mohammad Mehdi Akbarin; Hanieh Tarokhian; Hossein Rahimi; Alireza Bari; Hamid Reza Jahantigh; Seyed Abdolrahim Rezaee
Journal:  Med Microbiol Immunol       Date:  2017-05-02       Impact factor: 3.402

Review 2.  Updates on the Epidemiology of the Human T-Cell Leukemia Virus Type 1 Infection in the Countries of the Eastern Mediterranean Regional Office of the World Health Organization with Special Emphasis on the Situation in Iran.

Authors:  Mohammad Reza Hedayati-Moghaddam; Reza Jafarzadeh Esfehani; Hiba El Hajj; Ali Bazarbachi
Journal:  Viruses       Date:  2022-03-23       Impact factor: 5.818

3.  Human T lymphotropic virus type 1 and risk of cardiovascular disease: High-density lipoprotein dysfunction versus serum HDL-C concentrations.

Authors:  Sara Samadi; Samaneh Abolbashari; Zahra Meshkat; Amir Hooshang Mohammadpour; Theodoros Kelesidis; Aida Gholoobi; Mehrane Mehramiz; Mahla Tabadkani; Fatemeh Sadabadi; Razieh Dalirfardouei; Gordon A Ferns; Majid Ghayour-Mobarhan; Amir Avan
Journal:  Biofactors       Date:  2019-01-29       Impact factor: 6.113

4.  Adult T-cell leukemia: a review of epidemiological evidence.

Authors:  Masako Iwanaga; Toshiki Watanabe; Kazunari Yamaguchi
Journal:  Front Microbiol       Date:  2012-09-10       Impact factor: 5.640

5.  The Prevalence of Human T-Cell lymphotropic Virus Type 1 in Pregnant Women and Their Newborns.

Authors:  A Hamedi; F Akhlaghi; Z Meshkat; M Sezavar; H Nomani; M Meshkat
Journal:  ISRN Obstet Gynecol       Date:  2012-11-14

6.  The prevalence of HTLV-1 and its Co-Infection with HCV, HBV and HIV in Hemophilic patients.

Authors:  Masood Ziaee; Mohammad Hassan Namaei; Ghodseh Azarkar
Journal:  Pak J Med Sci       Date:  2015 Sep-Oct       Impact factor: 1.088

7.  Relative frequency of Human T-cell Lymphotropic Virus I/II in HIV/AIDS patients.

Authors:  Mohsen Meidani; Nooshin Ahmadi; Bahareh Jamali; Zahra Askarian
Journal:  Adv Biomed Res       Date:  2014-01-09

8.  No Evidence of HTLV-II Infection Among Immonoblot Indeterminate Samples Using Nested PCR in Mashhad, Northeast of Iran.

Authors:  Houshang Rafatpanah; Farhad Fathimoghadam; Majid Shahabi; Iman Eftekharzadeh; Mohammadreza Hedayati-Moghaddam; Narges Valizadeh; Mohsen Tadayon; Seyyed Aliakbar Shamsian; Hamidreza Bidkhori; Raheleh Miri; Ali Bazarbachi
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

Review 9.  A Systematic Review for Estimation of HTLV-I Infection in the Blood Donors of Iran.

Authors:  Mohammad Reza Hedayati-Moghaddam
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

Review 10.  "HTLV-I Infection" Twenty-Year Research in Neurology Department of Mashhad University of Medical Sciences.

Authors:  Ali Shoeibi; Mohammdmahdi Etemadi; Amir Moghaddam Ahmadi; Mona Amini; Reza Boostani
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.